Managed Access Is Ready for Its Clinical Trials Moment

The medicine may be free. The tax risk is not.

New Collaboration Helps Pharmaceutical Companies Generate Greater Value from Global Managed Access Programs

Managed Access Programs: Building the Evidence Infrastructure for Rare Disease.

From Operational Access to Strategic Advantage: How MFN Pricing is Reshaping MAPs

Maprium and The Medicine Access Channel partner

Webinar

Industry Veterans Launch Maprium